Increasing Transparency in Generic Drug Applications Act has not moved since its introduction on Apr 3, 2025, with cosponsors from both parties
IntroducedApr 3, 2025
Reported—
Passed one chamber—
Passed both—
Law—
What it changes · CRS summary
CRS has not published a summary of this bill yet. Read the bill text.
Context
- Committees
- Senate Health, Education, Labor, and Pensions Committee
- Policy area
- Health: 122 of 9,357 bills became law, 113th–118th (1.3%)
- Sponsor
- 3 of 248 bills enacted since 2013
- Text versions
- 1: introduced in senate · 679 words
- Latest action
- Apr 3, 2025: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Records
- Congress.gov · Bill text
Exhibit 1Passage odds band at each stage, rated when the bill reached it [4]
Related bills · 4
Each bill appears once, under its strongest link. 4 in all.
Related, per CRS or House · 4
- 119th H.R. 1768 Lower Costs for Everyday Americans Act D · Introduced
- 119th H.R. 1843 To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. R · Introduced
- 119th H.R. 7148 Consolidated Appropriations Act, 2026 R · Law
- 119th S. 891 Bipartisan Health Care Act D · Introduced
Exhibit 2Articles naming the bill per day, last 90 days, US sources [3]